Similar to MET amplification, RET kinase domain activation leads to the oncogenic signaling of BRAF-MEK-ERK, PI3K-AKT-mTOR and JNKs pathways (49), favoring cell survival and cancer development. Here, MAP2K7 is linked to cancer.